Stable isotope labeling for non-targeted data

By performing non-target feature extraction and target isotope extraction in the MS system, empirical molecular formulas are generated and corrected, the slow and error problems in analyzing non-target data in the prior art are solved, and fast and accurate detection of isotope incorporation is achieved .

CN111830112BActive Publication Date: 2024-11-26AGILENT TECHNOLOGIES INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202010286310.X
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-04-15
Filing Date
2020-04-13
Publication Date
2024-11-26
Estimated Expiration
2040-04-13

AI Technical Summary

Technical Problem

Existing MS-based stable isotope labeling tracing techniques operate slowly and may produce incorrect results when analyzing non-target data, making it difficult to accurately find random rather than continuous isotope incorporation.

Method used

By receiving mass spectral data generated by the MS system, non-target feature extraction and target isotope extraction are performed, empirical molecular formulas are generated, isotope patterns of unlabeled and labeled samples are compared, and stable labeled compounds are identified incorporated, using recursive feature extraction and molecular formulas. Generate algorithms to correct natural isotope abundance and tracer purity.

Benefits of technology

The detection speed and accuracy of isotope label incorporation are improved, and random and continuous isotope incorporation can be effectively discovered, reducing the error rate.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN111830112B_ABST
    Figure CN111830112B_ABST
Patent Text Reader

Abstract

A method for analyzing samples using stable isotope labeling tracers, the method comprising: receiving mass spectrometry (MS) data generated by an MS system that performs non-target data acquisition on multiple samples; performing non-target feature extraction on unlabeled compound data to generate a first extracted feature data set; generating multiple empirical molecular formulas corresponding to the first extracted features respectively; performing targeted isotopologue extraction on labeled compound data to generate a second extracted feature data set, wherein the targeted isotopologue extraction is based on the empirical molecular formula and retention time of each first extracted feature; and identifying one or more groups of isotopologues from the second extracted features.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] Related Applications

[0002] This application claims the benefit of U.S. Provisional Patent Application Serial No. 62 / 834,041, filed on April 15, 2019, entitled “STABLE LABEL ISOTOPE TRACING FOR UNTARGETED DATA,” under 35 U.S.C. §119(e), the contents of which are incorporated by reference in their entirety. Technical Field

[0003] The present invention generally relates to stable isotope labeling tracers used in conjunction with mass spectrometry (MS) for the acquisition, processing and analysis of non-targeted data. Background Art

[0004] Isotope tracing refers to a technique used to track the path or fate of an isotope in a (bio)chemical reaction or series of reactions, an example being a metabolic pathway in the case of metabolic processes taking place in biological cells. A chemical or biological compound can be isotopically labeled (or tagged) by intentionally replacing one or more atoms of the compound with atoms of the same element but with a different isotope than the original atom. For example, an isotopically labeled organic molecule can be obtained by replacing one or more atoms of the compound with carbon 13 ( 13 C) atoms replace one or more carbon 12 atoms of the molecule ( 12 The labeled compound is then subjected to or caused to undergo one or more reactions of interest. The product compounds of the reaction, including one or more positions and patterns of isotopes in the product compounds, can then be measured to obtain information such as the sequence or pathway taken by the isotopes through the reaction to reach the observed one or more compounds. Depending on the type of analysis performed, the reaction products of the isotope-labeled starting compound can be compared to the reaction products of the unlabeled counterpart. A "stable" isotope refers to a non-radioactive isotope (i.e., no radionuclides are involved). Commonly used stable isotopes in isotope tracing include carbon 13 ( 13 C), nitrogen 15 ( 15 N) and deuterium ( 2 H), but any element with more than one stable isotope can be used in isotope tracer experiments.

[0005] A technique for measuring stable isotope labels is mass spectrometry (MS). Typically, an MS system includes an ion source for ionizing components of a sample under investigation (including isotope-labeled compounds), a mass spectrometer for separating the resulting ions according to their different mass-to-charge ratios (or m / z ratios, or more simply "mass"), an ion detector for counting separated ions, and an electronic device for processing the output signal from the ion detector as needed to generate user-interpretable data in the form of a chromatogram or mass spectrogram. Typically, a mass spectrum is a series of peaks that indicate the relative abundance of the detected ions (e.g., ion signal intensity, such as the number of ion counts for each ion detected) as a function of its m / z ratio. A mass spectrum or MS / MS fragment spectrum can be used to determine the molecular structure of the sample components, thereby enabling the sample to be qualitatively and quantitatively characterized, including the identification, abundance, distribution, and differences between isotopomers of each compound observed in the analysis. Therefore, when applied to biological processes, mass spectrometry can be used for quantitative metabolic flux analysis (MFA) or qualitative flux analysis (stable isotope tracing).

[0006] Mass spectrometry techniques can be enhanced by combining them with another analytical separation technique before the MS analysis stage. Examples include chromatographic techniques, such as liquid chromatography (LC) or gas chromatography (GC). For example, in an LC system, a mobile phase consisting of one or more solvents is driven by pressure through a chromatographic column. The LC column contains a stationary phase, which is typically provided in the form of a packed bed of particles (such as chemically modified porous silica beads) in LC. The particles are formulated and / or functionalized to separate different components (e.g., chemical compounds) of a sample. The sample to be processed by the LC system is injected into the mobile phase at a position upstream of the column. Then, due to the flow generated by the high system pressure, the sample is transported through the column with the mobile phase. When the sample flows through the column, the sample contacts the stationary phase. Different components of the sample have different affinities for the stationary phase. This can cause different components to be separated from each other in the liquid flow through the column. Therefore, different components are eluted from the column outlet at different times. Therefore, the liquid flow output from the column contains a series of spectral bands, each of which is composed of unique components of the sample. That is, the bands are composed of different components of the sample, which are separated from each other by the column. In a GC system, the mobile phase is the carrier gas that carries the gas phase sample through the GC column, and the stationary phase in the GC column can be the lining of the column. In addition, other techniques besides LC or GC can also be used as the first stage of analytical separation, such as electrophoresis-based techniques, such as capillary electrophoresis (CE).

[0007] In a hybrid LC / MS, GC / MS or CE / MS system, separated compounds eluted from a column or electrophoresis apparatus (e.g., a CE capillary) are introduced into the ion source of the MS system, and the MS system processes the separated compounds as described above. A hybrid MS system can combine the advantages of a first-stage analytical separation technique (e.g., LC, GC, or CE) and a second-stage analytical separation technique (MS). For example, a hybrid MS system is capable of acquiring three-dimensional (3D) LC / MS, GC / MS, or CE / MS data from a sample characterized by retention time (or elution time or acquisition time), ion abundance, and m / z sorted by the MS system. Multidimensional MS data is very useful for measuring and distinguishing different compounds of a complex sample. For example, two different compounds may elute together from a chromatographic column at approximately the same time, but because they have different masses, they can then be separated by the MS system to avoid peak overlap in the data, assuming the MS system is operated at a high enough resolution.

[0008] Traditionally, sample analysis using MS-based stable isotope labeling has been targeted or biased, where a limited number of known compounds are measured. Recently, non-targeted (unbiased) methods for analyzing samples containing unknown compounds are being investigated to expand the analytical capabilities of MS-based stable isotope labeling and generate more comprehensive information.

[0009] An example of a non-target method is to use X 13 CMS software. See Huang et al., X 13 CMS: Global Tracking of Isotopic Labels in Untargeted Metabolomics, Anal. Chem., 86, pp. 1632-1639, American Chemical Society (2014). X 13 The CMS software analyzes data acquired from both unlabeled samples and labeled samples run through the LC / MS system. 13 CMS software can search for characteristic groups in both unlabeled and labeled samples in a non-targeted manner. In this context, a "characteristic group" is a set of ions that are isotopic clusters at a given retention time. Then, X 13 The CMS software compares characteristic groups to find isotopologue differences. However, 13 Known non-targeted data analysis techniques implemented by the CMS software may be slow to operate and produce erroneous results, such as isotope gaps and incorrect isotope clusters, and may fail to find random rather than sequential isotope incorporation.

[0010] Therefore, there is a need for improved methods and systems for stable isotope labeling for non-targeted data. Summary of the invention

[0011] To fully or partially solve the above problems and / or other problems that may have been observed by those skilled in the art, the present disclosure provides methods, processes, systems, devices, instruments and / or equipment, as described by the examples in the embodiments set forth below.

[0012] According to one embodiment, a method for analyzing samples using stable isotope labeling for tracing includes: (a) receiving mass spectrometry (MS) data generated by an MS system that performs non-target data acquisition on multiple samples, wherein: the multiple samples include: unlabeled samples containing unlabeled compounds, and labeled samples containing isotope-labeled compounds and chemically or biologically equivalent to the unlabeled samples; the MS data includes unlabeled compound data and labeled compound data; the unlabeled compound data includes retention time data, mass-to-charge ratio (m / z) data and abundance data corresponding to the molecular features of the unlabeled samples detected by the MS system; the labeled The compound data comprises retention time data, m / z data and abundance data corresponding to the molecular features of the labeled sample detected by the MS system; (b) performing non-target feature extraction on the unlabeled compound data to generate a first extracted feature data set; (c) generating multiple empirical molecular formulas corresponding to the first extracted features respectively; (d) performing targeted isotopologue extraction on the labeled compound data to generate a second extracted feature data set, wherein the targeted isotopologue extraction is based on the empirical molecular formula and retention time of each first extracted feature; and (e) identifying compounds incorporating stable labels by observing changes in the isotopologue pattern in the second extracted feature compared to the natural pattern.

[0013] In one embodiment, the unlabeled compound and the isotopically labeled compound are non-biological compounds. In another embodiment, the unlabeled compound and the isotopically labeled compound are biological compounds.

[0014] In one embodiment, the MS data comprises chromatography / MS data. In another embodiment, the MS data comprises capillary electrophoresis / MS data.

[0015] In one embodiment, the receiving is accomplished at a computing device including a processor and a memory.

[0016] In one embodiment, performing untargeted feature extraction on the unlabeled compound data includes performing recursive feature extraction.

[0017] In one embodiment, the method includes removing low abundance features from the first extracted feature dataset prior to generating the plurality of empirical formulas, wherein the low abundance features have an abundance below a minimum abundance threshold.

[0018] In one embodiment, the method includes performing a retention time alignment on the first extracted feature data set prior to generating the plurality of empirical formulas.

[0019] In one embodiment, generating multiple empirical molecular formulas includes at least one of the following steps: executing a molecular formula generation algorithm, which is configured to assign empirical molecular formulas to corresponding first extracted features based on isotope pattern matching; and executing a molecular formula generation algorithm, which is configured to assign empirical molecular formulas to corresponding first extracted features based on comparing the first extracted features with known compounds contained in a database.

[0020] In one embodiment, the method further comprises removing unassigned features from the first extracted feature dataset prior to performing the target isotopologue extraction, wherein the unassigned features are features that cannot be associated with a molecular formula after performing the molecular formula generation algorithm.

[0021] In one embodiment, generating a plurality of empirical formulas includes executing a formula generation algorithm configured to assign scores to first extracted features, with higher scores indicating closer isotope pattern matches; assigning empirical formulas to corresponding first extracted features having scores equal to or greater than a minimum score threshold; and removing low-scoring features from the first extracted feature data set, wherein the scores of the low-scoring features are below the minimum score threshold.

[0022] In one embodiment, the method includes performing a natural isotope abundance correction on the unlabeled compound data and the labeled compound data after performing the target isotopologue extraction.

[0023] In one embodiment, the labeled sample is prepared by applying an isotopic tracer to the labeled sample, and the method further comprises performing an isotopic tracer purity correction on the labeled compound data after performing the target isotopologue extraction.

[0024] In one embodiment, the method includes removing unidentified isotopologues from a first extracted feature dataset and removing unidentified isotopologues from a second extracted feature dataset after performing target isotopologue extraction.

[0025] In one embodiment, the unlabeled compound and the isotope-labeled compound are, respectively, a first unlabeled compound and a first isotope-labeled compound extracted from a sample source at a first time point; the MS data is first MS data collected from the first unlabeled compound and the first isotope-labeled compound; and the method further includes repeating steps (a)-(e) at a second time point after the first time point using second MS data collected from a second unlabeled compound and a second isotope-labeled compound extracted from the sample source.

[0026] In one embodiment, the sample source is a biological system, the first unlabeled compound and the first isotopically labeled compound are first metabolites, and the second unlabeled compound and the second isotopically labeled compound are second metabolites.

[0027] In one embodiment, the unlabeled sample is an unlabeled control sample, the labeled sample is a labeled control sample, the first extracted feature is the first extracted feature of the unlabeled control sample, and the second extracted feature is the second extracted feature of the labeled control sample; the multiple samples further include an unlabeled test sample and a labeled test sample, the unlabeled test sample and the labeled test sample are chemically or biologically equivalent to the unlabeled control sample and the labeled control sample, and have chemical or biological conditions that are changed relative to the chemical or biological conditions of the unlabeled control sample and the labeled control sample; and the method further includes performing steps (a)-(e) on the unlabeled test sample and the labeled test sample to generate a data set of extracted features of the unlabeled test sample and extracted features of the labeled test sample.

[0028] In one embodiment, the method further comprises, after performing the target isotopologue extraction, performing a differential analysis to determine the difference between the isotopic patterns of the unlabeled control sample and the labeled control sample and the isotopic patterns of the unlabeled test sample and the labeled test sample.

[0029] In one embodiment, the unlabeled control sample, the labeled control sample, the unlabeled test sample, and the labeled test sample comprise metabolites.

[0030] According to another embodiment, a system for analyzing a sample using stable isotope labeling includes a controller configured to receive MS data and control or execute all or part of any of the methods disclosed herein.

[0031] According to another embodiment, a non-transitory computer-readable storage medium includes instructions for performing all or part of any of the methods disclosed herein.

[0032] According to another embodiment, a system includes a computer-readable storage medium.

[0033] After reviewing the following drawings and detailed description, other devices, apparatuses, systems, methods, features and advantages of the present invention will be apparent to those skilled in the art. All of these additional systems, methods, features and advantages are intended to be included in this specification, fall within the scope of the present invention, and be protected by the appended claims. BRIEF DESCRIPTION OF THE DRAWINGS

[0034] The present invention may be better understood with reference to the following drawings. The components in the drawings are not necessarily to scale, emphasis being placed on illustrating the principles of the present invention. In the drawings, the same reference numerals indicate corresponding parts in different views.

[0035] Figure 1A is a schematic diagram of an example of a mass spectrometry (MS) system, according to one embodiment, that can be used to implement the subject matter described herein.

[0036] Figure 1B is a schematic diagram of an example of a computing device and / or data analyzer that may be used to implement the subject matter described herein.

[0037] Figure 2 is a graph (or collection or list) of examples of raw 3D LC / MS data acquired from sample molecules.

[0038] Figure 3 is a schematic diagram of an example of an extracted ion chromatogram (EIC) as a Figure 2 An example of a plot (or set or list) of 2D data extracted from the 3D LC / MS data shown in .

[0039] Figure 4 is a schematic diagram of an example of a system or workflow for data acquisition and analysis of a sample according to the present disclosure, involving stable isotope labeling tracing.

[0040] Figure 5 is a flow chart of an example of a method 500 for analyzing a sample using a stable isotope labeled tracer according to the present disclosure.

[0041] Fig. 6A is a screenshot showing an example of output data resulting from implementing a method for analyzing a sample according to the present disclosure.

[0042] Figure 6B is similar to Fig. 6A A screenshot of Figure 1 shows an example of output data from the same experiment but after natural abundance correction has been performed.

[0043] Figure 7is a schematic diagram of another example of a system or workflow for data acquisition and analysis of a sample according to the present disclosure, involving stable isotope labeling tracing. DETAILED DESCRIPTION

[0044] Figure 1A 1 is a schematic diagram of an example of a mass spectrometry (MS) system 100 according to one embodiment that can be used to implement the subject matter described herein. The operation and design of the various components of an MS system are generally known to those skilled in the art and therefore do not require detailed description herein. Instead, certain components are briefly described to facilitate understanding of the subject matter disclosed herein.

[0045] The MS system 100 may generally include an ion source 104, a mass spectrometer (MS) 116, and a computing device (or computer or system controller) 118. In some embodiments, the mass spectrometer system 100 may also include an intermediate ion processing section 112 that is generally used as an interface (or intermediate portion or region) between the ion source 104 and the MS 116. Generally, the ion processing section 112 may represent one or more ion processing components (structures, equipment, regions, etc.) between the ion source 104 and the MS 116. These components may provide various functions, such as decompression, neutral gas removal, ion capture / gating, ion beam focusing / guiding, ion mass filtering / selection, ion fragmentation, etc. As understood by those skilled in the art, examples of intermediate components include, but are not limited to, ion optical devices, ion traps, multipole ion guides, stacked ring ion guides, drift chambers, collision chambers, ion funnels, etc. The ion processing section 112 may include a housing that encloses one or more chambers. Each chamber may include one or more such components.

[0046] The MS system 100 also includes a vacuum system for maintaining various internal regions or chambers of the MS system 100 at a controlled sub-atmospheric pressure level. Vacuum lines 124 and 128 schematically depict the vacuum system. Vacuum lines 124 and 128 schematically represent one or more vacuum generating pumps and associated piping and other components as understood by those skilled in the art. Vacuum lines 124 and 128 can also remove any residual non-analytical neutral molecules from the ion path through the MS system 100.

[0047] Ion source 104 can be any type of continuous beam or pulse ion source suitable for producing analyte ions for spectrometry. In a typical embodiment, ion source 104 is an electrospray ionization (ESI) source. However, depending on the configuration of MS system 100, sample to be analyzed, analytical separation instrument connected to ion source 104, etc., other types of ion sources can be utilized. The example of other ion sources 104 includes but is not limited to, other types of spray type equipment (for example, thermal spray ionization equipment, sonic spray equipment, etc.), other types of atmospheric pressure ionization (API) source, photoionization (PI) source, electron ionization (EI) source, chemical ionization (CI) source, field ionization (FI) source, plasma or corona discharge source, fast atom bombardment (FAB) source, laser desorption ionization (LDI) source and matrix-assisted laser desorption ionization (MALDI) source. In some embodiments, ion source 104 can include two or more ionization devices, which can be the same type or different types. Depending on the type of ionization being performed, the ion source 104 may reside within a vacuum chamber, or may operate at or near atmospheric pressure. The sample material to be analyzed may be introduced to the ion source 104 by any suitable means, including hyphenated techniques, wherein the sample material is the output 136 of an analytical separation instrument 138, such as, for example, a liquid chromatography (LC) instrument, a gas chromatography (GC), a capillary electrophoresis (CE) instrument, or the like.

[0048] MS 116 may generally include a mass analyzer 148 and an ion detector 150 enclosed in a housing. Vacuum line 128 maintains the interior of MS 116 at an extremely low (vacuum) pressure (e.g., at 10 -4 Up to 10 -9 Torr range). The mass analyzer 148 separates analyte ions based on the different mass-to-charge ratios (m / z) of the ions. In some embodiments, the mass analyzer 148 is a time-of-flight (TOF) analyzer. The TOF analyzer includes an ion pulser (or extractor) and a flight tube that is generally free of an electric field. The entrance optics guide the ion beam into the ion pulser, which pulses the ions into the flight tube as ion packets. The ions drift toward the ion detector 150 through the flight tube. Ions of different masses pass through the flight tube at different speeds and therefore have different total flight times, that is, ions of smaller mass move faster than ions of larger mass. Each ion packet is spread (dispersed) in space according to the flight time distribution. The ion detector 150 detects and records the time when each ion arrives (impacts) the ion detector 150. The data acquisition process of the computing device 118 associates the recorded flight time with the m / z ratio.

[0049] More generally, various types of mass analyzers other than TOF analyzers may be used in MS system 100. Examples include, but are not limited to, multipole electrode structures (e.g., quadrupole mass filters, linear ion traps, Paul three-dimensional traps, etc.), electrostatic traps (e.g., Kingdon, Knight, and trap), ion cyclotron resonance (ICR) or Penning trap (such as used in Fourier transform ion cyclotron resonance mass spectrometer (FT-ICR or FTMS)), sector electric field instrument, sector magnetic field instrument, etc.

[0050] Ion detector 150 may be any device configured to collect and measure the flux (or current) of mass differentiated ions output from mass analyzer 148. Examples of ion detector 150 include, but are not limited to, a multichannel plate (MCP), an electron multiplier (Em), a photomultiplier tube, and a Faraday cup.

[0051] In some embodiments, MS 116 can be combined with ion processing section 112 to form a tandem MS or MS n System. As an example, the ion processing section 112 may include an ion guide configured as a quadrupole mass filter for selecting ions of a specific m / z or m / z range, and another multipole ion guide configured as non-mass-resolved, a radio frequency (RF) collision cell only for producing fragment ions. In the collision cell, ions collide with a collision gas (e.g., argon, nitrogen, helium, etc.). The gas pressure is high enough to fragment ions (with sufficient energy) that collide with gas molecules into smaller ions by a mechanism called collision-induced dissociation (CID). The fragment ions are then transferred to the mass analyzer 148.

[0052] If provided in the MS system 100, the ion fragmentation device may have a configuration other than a CID-based device. For example, the ion fragmentation device may be configured to perform electron capture dissociation (ECD), electron transfer dissociation (ETD), infrared multiphoton dissociation (IRMPD), etc.

[0053] As will be appreciated by those skilled in the art, the spectroscopy systems disclosed herein may include various other ion optical devices positioned along the ion path that are not specifically described above or shown in the accompanying drawings. As will be appreciated by those skilled in the art, such ion optical devices may be configured to control or manipulate (e.g., focus, shape, manipulate, cool, accelerate, decelerate, slice, etc.) an ion beam.

[0054] The computing device (or system controller, or controller) 118 is schematically depicted as representing one or more modules (or units, or components) configured to control, monitor and / or time various functional aspects of the MS system 100, such as, for example, the upstream analytical separation instrument 138, the ion source 104, one or more components of the ion processing section 112, and the MS 116, as well as other components that may be provided in the MS system 100 but not in the MS system 100. Figure 1A Any vacuum pump, ion optical device, sample introduction device, etc. specifically shown in the. One or more modules (or units, or components) can be, for example, a desktop computer, a laptop computer, a portable computer, a tablet computer, a handheld computer, a mobile computing device, a personal digital assistant (PDA), a smart phone, etc. or embodied therein. The computing device 118 can also schematically represent all voltage sources not specifically shown, as well as the timing controller, clock, frequency / waveform generator, etc. required to apply voltage to the various components of the MS system 100. The computing device 118 can also be configured to receive ion detection signals from the ion detector 150, and perform tasks related to data acquisition and signal analysis as needed to generate chromatograms, drift spectra, and mass spectra (m / z) spectra that characterize the sample being analyzed. The computing device 118 can also be configured to provide and control a user interface that provides a screen display of spectral data and other data that a user can interact with. The computing device 118 may include one or more reading devices, on which or in which a non-transient computer-readable (machine-readable) medium can be loaded, and the computer-readable medium includes instructions for executing all or part of any method disclosed herein. For all such purposes, computing device 118 may be in signal communication with various components of MS system 100 via wired or wireless communication links (eg, represented in part by the dashed line between computing device 118 and MS 116).

[0055] The computing device 118 may include a data analyzer 190 (or a data analysis module, unit, or component) configured to analyze the MS data generated by the MS system 100 according to any of the methods disclosed herein. Alternatively, the data analyzer 190 may be a separate component (such as may be embodied in a separate computing device) that communicates with the computing device 118 to receive the MS data therefrom via a wired or wireless communication link, or is otherwise configured to receive and read the MS data in a non-transitory format (such as may be stored in memory or a drive). In general, the computing device 118 and the data analyzer 190 may include or be embodied in one or more types of hardware, firmware, and / or software and one or more memories and databases.

[0056] Figure 1B1 is a schematic diagram of an embodiment of a computing device 118 and / or a data analyzer (e.g., data analyzer 190 described in the embodiments herein) that can be used to implement the subject matter described herein. Data analyzer 190 can be a combination of the above Figure 1A 118, or may be (a part of) a device separate or remote from such computing device 118. Thus, computing device 118 may include data analyzer 190, communicate with data analyzer 190, or at least serve as a source of data to be processed or analyzed by data analyzer 190. Thus, alternatively or additionally, in Figure 1B One or more components shown as part of the data analyzer 190 in the figure may be shared with or be part of the computing device 118. In the illustrated embodiment, the data analyzer 190 includes an electronically based processor 162, which may represent a main electronic processor that provides overall control; and one or more electronic processors configured for dedicated control operations or specific signal processing tasks (e.g., a graphics processing unit or GPU, a digital signal processor or DSP, an application-specific integrated circuit or ASIC, a field programmable gate array or FPGA, etc.). The data analyzer 190 also includes one or more memories 164 (volatile and / or non-volatile) for storing data and / or software. The data analyzer 190 may also include one or more device drivers 166 for controlling one or more types of user interface devices and providing an interface between the user interface device and the components of the data analyzer 190 that communicate with the user interface device. Such user interface devices may include user input devices 168 (e.g., keyboards, keypads, touch screens, mice, joysticks, trackballs, etc.) and user output devices 170 (e.g., display screens, printers, visual indicators or alarms, audible indicators or alarms, etc.). In various embodiments, the data analyzer 190 may be considered to include one or more user input devices 168 and / or user output devices 170, or at least be considered to be in communication with them. The data analyzer 190 may also include one or more types of computer programs or software 172 contained in a memory and / or one or more types of computer readable media 174. The computer program or software may include instructions (e.g., logical instructions) for performing all or part of any method for analyzing a sample disclosed herein. The computer program or software may also include application software and system software. System software may include an operating system (e.g., Microsoft Windows XP) for controlling and managing various functions of the data analyzer 190. The data analyzer 190 may include an operating system, including an interaction between hardware and application software. In particular, the operating system may provide a graphical user interface (GUI) displayed via a user output device 170 such as a display screen, and a user may interact with the graphical user interface using a user input device 168 such as a keyboard or a pointing device (e.g., a mouse). The data analyzer 190 may also include one or more data analyzer modules 176 (which may be embodied in hardware, firmware, and / or software, including algorithms), which are specifically configured to perform one or more steps of the method for analyzing a sample disclosed herein.

[0057] It should be understood that Figure 1A and Figure 1B 1 is a high-level schematic diagram of an embodiment of an MS system 100 and associated computing device 118 and data analyzer 190 consistent with the present disclosure. Other components may be included as desired for the actual implementation, such as additional structures, vacuum pumps, gas lines, ion optics, ion guides, electronics, and computer-related or electronic processor-related components. It should also be understood that the computing device 118 and data analyzer 190 are not limited to the MS system 100 and the associated computing device 118 and data analyzer 190. Figure 1A and 1B Schematically represented in the figure are functional blocks intended to represent structures (e.g., circuits, mechanisms, hardware, firmware, software, etc.) that may be provided. The various functional blocks and signal links are arbitrarily placed for illustrative purposes only and are not limiting in any way. Those skilled in the art will understand that in practice, the functions of the computing device 118 and the data analyzer 190 may be implemented in various ways and not necessarily in a configurable manner. Figure 1A and Figure 1B The invention can be implemented in the exact manner shown and described herein.

[0058] In operation, a chemical or biological sample is introduced into the MS system 100 by first inputting the sample into the analytical separation instrument 138. The analytical separation instrument 138 performs the first dimension or stage of analytical separation, and separates the sample into constituent chemical or biological compounds according to the operating principle (chromatography, electrophoresis, etc.) of the analytical separation instrument 138. The compounds separated from each other elute from the analytical separation instrument 138 as output 136 at different retention times (or elution times). Different compounds elute at different times, and therefore have different detectable retention times. Certain groups of the compound may be different from each other, but still co-elute at about the same time (i.e., within the same retention time window). The co-eluted compounds can be further resolved by MS 116, which can perform analytical separation of the second dimension or the second stage. Therefore, the compound output from the analytical separation instrument 138 is subsequently introduced into the ion source 104. The ion source 104 ionizes the compound, that is, the analyte ion is formed by the compound. The analyte ions can then be subjected to a processing step suitable for the method in the ion processing section 112 and then transferred to the mass analyzer 148. The mass analyzer 148 separates the received analyte ions based on m / z (or flight time, depending on the embodiment), and the separated ions then arrive at the ion detector 150. The ion detector 150 records the time at which it receives the mass-separated ions, counts the number of ions received at these times, and sends this information to the computing device 118 as an electronic ion measurement signal. The computing device 118 processes the signals received from the ion detector 150 to generate raw multidimensional MS data associated with each different ion mass detected. For example, the MS data can be three-dimensional (3D) data, in which three data points are associated with each different ion mass (peak) detected, i.e., retention time, m / z, and abundance. In this context, "raw" data is data that has not yet been processed by the data analyzer 190.

[0059] As a non-exclusive embodiment, Figure 2 is a graph (or collection or list) of raw 3D LC / MS data collected from sample molecules. In a particular embodiment, the raw 3D LC / MS data is collected by running the sample through an LC instrument as an analytical separation instrument 138, and then through the mass spectrometer portion of the MS system 100, and then transmitting the detector output to the computing device 118 for use as described above and in Figure 1A Further processing is shown. Figure 2 The data sets shown in may be stored in a memory of the computing device 118 and later transferred to a memory of the data analyzer 190, such as Figure 1B The memory 164 shown in . Figure 2 is a graphical illustration of the dataset. Figure 2It may also correspond to the display of data, such as in the user output 170 ( Figure 1B ) such as provided at a display screen of data analyzer 190 (or computing device 118).

[0060] exist Figure 2 In , the raw 3D LC / MS data is displayed as a 3D plot defined by two horizontal axes and one vertical axis. The two horizontal axis dimensions are elution (retention) time (in minutes or min) and m / z. The vertical axis dimension is the ion signal intensity or ion abundance (total number of ion counts). The values ​​of m / z, elution time, and intensity are the molecular features from which the 3D LC / MS data was collected.

[0061] For any given elution time, a 2D plot (or set or list) of intensity versus m / z, i.e., a mass spectrum, can be extracted from the 3D LC / MS data. For any given m / z, a 2D plot (or set or list) of intensity versus elution time, i.e., a chromatogram, can be extracted from the same 3D LC / MS data. The extracted data set can be used in an algorithm that can be part of the methods disclosed herein. As a non-exclusive example, Figure 3 The extracted ion chromatogram (EIC) is shown as Figure 2 An example of a plot (or set or list) of 2D data extracted from the 3D LC / MS data shown in . The vertical axis corresponds to Figure 2 The horizontal axis corresponds to the elution time axis. Figure 3 As shown by the vertical dashed line and horizontal double arrow in , the EIC can be filtered to include only data within a selected elution time range within one or more specific m / z ranges.

[0062] Once the raw MS data has been collected, it can be analyzed by the data analyzer 190 to search for and identify molecules in the sample under analysis. In one embodiment, the data analyzer 190 is configured to perform stable isotope labeling tracing. Isotopes can be used to track isotopes as they proceed through chemical or biological reaction tracings such as metabolic pathways (e.g., metabolic flux analysis or MFA).

[0063] Figure 4 400 is a schematic diagram of an example of a system or workflow 400 for data acquisition and analysis of a sample according to the present disclosure, involving stable isotope labeling and tracing. Generally, the system or workflow 400 requires a sample preparation phase 404, a sample processing and analysis phase 408, and a data processing and analysis phase 412 to be performed in sequence.

[0064] During the sample preparation stage 404, an unlabeled sample 420 and an isotope-labeled sample 424 are prepared. Samples 420 and 424 can be chemical (non-biological) samples or biological samples. Unlabeled sample 420 includes compounds that have not been intentionally labeled with isotopes. In this context, unlabeled compounds are either completely free of isotopes or include naturally occurring (natural abundance) isotopes. Labeled sample 424 includes at least one compound that has been isotopically labeled. Isotope-labeled sample 424 can be prepared by treating an initially unlabeled sample with a reagent or medium containing an isotope of interest and then incorporating the isotope into the compounds of the initially unlabeled sample. Commonly used isotopes include, but are not limited to, carbon 13 ( 13 C), nitrogen 15 ( 15 N) and deuterium ( 2 H). In addition to isotopic enrichment, the isotope-labeled sample 424 is chemically or biologically equivalent to the unlabeled sample 420. In this context, "chemically equivalent" means that the stable labeled spiked version of the chemical sample is a replica of the unlabeled version of the sample, wherein one or more unlabeled compounds are replaced by the stable labeled compound. Also in this context, "biologically equivalent" means that the stable labeled spiked version of the biological sample is a replica of the unlabeled version of the sample, wherein one or more unlabeled compounds are replaced by the stable labeled compound.

[0065] During the sample processing and analysis phase 408, unlabeled sample 420 and isotope labeled sample 424 are each introduced and run through an MS system, such as described above and in Figure 1A The MS system 100 is shown in FIG. 4. The MS system 100 generates raw MS data 476 corresponding to each peak detected and sends the raw MS data 476 to the data analyzer 190.

[0066] During the data processing and analysis phase 412, the data analyzer 190 receives raw MS data 476 from the MS system 100 or another source that may have stored the MS data 476, and processes and analyzes the raw MS data 476 according to the methods described herein. For example, the data analyzer 190 can extract features from the raw MS data 476, analyze the features (e.g., perform statistical analysis, pathway analysis, etc.), identify the features by compound, and identify and group the isotopologues of the identified compounds. Based on the analysis, the data analyzer 190 generates output data 440. The output data 440 may include a list of compounds identified as being present in the samples 420 and 424, as well as other information, such as a list and grouping of isotopologues. The user can then use the output data 440 for further analysis and interpretation, such as determining the flux and pathway taken by the isotopologue through one or more reactions.

[0067] Figure 5 500 is a flow chart of an example of a method for analyzing a sample using a stable isotope labeled tracer according to the present disclosure. The method 500 may be implemented, for example, by operating a data analyzer, such as described herein and in Figure 1A and 1B The method 500 may be implemented, for example, as part of a system or workflow, such as described above and in Figure 4 The system or workflow 400 is shown in FIG.

[0068] In the method, MS data is received by, for example, a data analyzer 190 (step 502). MS data is data generated by an MS system, such as the MS system 100 described herein, after operating the MS system to perform non-targeted data acquisition on multiple samples described herein. In this context, non-targeted (or non-biased) data acquisition refers to a process in which data is acquired and processed not only from a limited number of known target compounds but also from all peaks detected by the MS system during a sample run. Multiple samples include at least one unlabeled sample 420 comprising unlabeled (chemical or biological) compounds and at least one labeled sample 424 comprising isotopically labeled (chemical or biological) compounds, the samples being chemically or biologically equivalent as described above. The MS data includes unlabeled compound data and labeled compound data. The unlabeled compound data includes retention time data, mass-to-charge ratio (m / z) data, and abundance data corresponding to molecular features of the unlabeled sample detected by the MS system, such as in Figure 2 In the illustrated embodiment, the labeled compound data also includes retention time data, m / z data, and abundance data corresponding to the molecular features of the labeled sample detected by the MS system.

[0069] Samples 420 and 424 may be run sequentially through the MS system under identical operating conditions, instrument settings, etc. A desired number of replicates of each unlabeled sample 420 and each isotopically labeled sample 424 may be run through the MS system to generate MS data.

[0070] After receiving the MS data, the data analyzer 190 performs non-target feature extraction to generate the first extracted feature data set (step 506) to the unlabeled compound data. The feature extraction process used here is "non-target" because the feature is extracted from all unlabeled compound data collected in the sample run. The data analyzer 190 can perform any feature extraction algorithm that can be used for this purpose. An example is the molecular feature extraction (MFE) algorithm provided as a part of the MASSHUNTER software, which can be purchased from the Agilent Technologies company in Santa Clara, California, USA.

[0071] In one embodiment, the algorithm for non-target feature extraction can be configured to perform recursive feature extraction. In addition, one or more filtering techniques can be used to improve the results of non-target feature extraction. For example, the filtering technique can include removing low abundance features from the first extracted feature data set, wherein the low abundance features have an abundance (measured ion signal intensity) below a preset minimum abundance threshold.

[0072] After generating the first extracted feature data set, the data analyzer 190 generates or calculates a plurality of empirical molecular formulas corresponding to the first extracted features, respectively (step 510). The molecular formula for the first extracted feature can be generated by using a suitable algorithm, an example of which is the molecular formula generation (MFG) algorithm available as part of the MassHunter qualitative analysis software, which can be purchased from Agilent Technologies. As an example, the algorithm can be configured to assign empirical molecular formulas to the corresponding first extracted features based on isotope pattern matching. Alternatively, the algorithm can be configured to assign empirical molecular formulas to the corresponding first extracted features based on comparison of the first extracted features with known compounds contained in an appropriate molecular formula database. An example is the Agilent-METLIN database available from Agilent Technologies. Using a molecular formula database may result in a more accurate molecular formula, but only if the first extracted feature corresponds to a known compound. In either case, the generation of empirical formulas results in a feature list with retention times, which is then used as a target list from which features and their isotopologues can be extracted.

[0073] As another embodiment, an empirical molecular formula can be generated by executing a molecular formula generation algorithm, wherein the molecular formula generation algorithm is configured to assign scores to the first extracted features, with higher scores indicating closer isotope pattern matches. The molecular formula is assigned to the corresponding first extracted features having scores equal to or greater than a preset minimum score threshold. Low-scoring features (features with scores below the minimum score threshold) are removed from the first extracted feature data set.

[0074] In one embodiment, before generating an empirical formula, a retention time alignment can be performed on the first extracted feature data set to ensure that all observed compounds are correctly aligned. To this end, the data analyzer 190 can allow the user to set a retention time window (e.g., in minutes) and a mass window (e.g., in parts per million or ppm or Daltons or Da).

[0075] In one embodiment, before performing the target isotopologue extraction, unassigned features may be removed from the first extracted feature dataset. Unassigned features are features that cannot be associated with a molecular formula after executing the molecular formula generation algorithm.

[0076] After generating the empirical formula, the data analyzer 190 performs a target isotopologue extraction on the labeled compound data to generate a second extracted feature data set (step 514). The target isotopologue extraction is based on the empirical formula and retention time of each first extracted feature. The target isotopologue extraction can be performed by using a suitable algorithm, an example of which is a batch isotopologue extraction algorithm that can be obtained as part of the above-mentioned MASSHUNTER software.

[0077] In one embodiment, after performing target isotopologue extraction, natural isotope abundance correction can be performed on the unlabeled compound data and the labeled compound data to improve the accuracy of isotopologue identification. In addition, isotope tracer purity correction can be performed on the labeled compound data to improve accuracy.

[0078] In one embodiment, after performing the target isotopologue extraction, and preferably after performing any correction techniques such as natural isotope abundance correction and isotopic tracer purity correction, the method may include removing the first extracted features for which the isotopologue is not identified from the first extracted features dataset, and removing the second extracted features for which the isotopologue is not identified from the second extracted features dataset.

[0079] After the second extracted feature data set is generated, one or more compounds incorporating the stable label are identified, i.e., stable label incorporation is determined to have occurred, by observing changes in the isotopologue pattern in the second extracted feature compared to the natural pattern - i.e., by comparing the isotopologue pattern in the first extracted feature with the isotopologue pattern in the second extracted feature to determine whether there is a difference (particularly a statistically significant difference) between the corresponding isotopologue patterns (step 518). For example, the (statistically significant) difference can be determined by evaluating the relative ratio heights of different isotopologues.

[0080] In the present context, an isotopic group consists of a base compound and all isotopologues of said base compound observed in a sample in an analysis.

[0081] The method can be used in a time course to track the path of an isotope through a reaction pathway in a reaction occurring in a chemical or biological sample, such as a metabolic pathway in the case of a biological sample. To this end, unlabeled and labeled samples can be extracted from their corresponding sample sources (e.g., containers containing chemical mixtures, biological systems such as cell cultures) at two or more consecutive time points and run through an MS system to collect data corresponding to different time points. Therefore, depending on the number of time points, steps 502-516 can be repeated one or more times.

[0082] Thus, in one embodiment of the method, in a first iteration, the unlabeled compound and the isotopically labeled compound are the first unlabeled compound and the first isotopically labeled compound extracted from the sample source at the first time point, respectively. Figure 5 The first MS data is collected from the first unlabeled compound and the first isotope-labeled compound in the manner shown in FIG. Subsequently, at a second time point after the first time point, second MS data is collected from the second unlabeled compound and the second isotope-labeled compound extracted from the sample source in the same manner. Other iterations can be performed for other time points as needed.

[0083] Fig. 6A It is a screenshot of an example of output data obtained by implementing the method for analyzing samples according to the present disclosure. The screenshot can be generated by the GUI provided by data analyzer 190 or relevant computing equipment. The screenshot includes several windows containing different types of output data. A window includes a list of compound groups observed in the sample, and the information of each compound group, such as name, molecular formula and retention time. The user has selected a compound group (the 29th group), as shown in the highlighted display. Other windows may include data specific to the selected compound group, such as the chromatogram of count (abundance or signal intensity) and acquisition (retention) time (in min), the mass spectrogram of count and m / z (in m / z or Da), and the histogram of the percentage (%) distribution of the isotopologue (m, m+1, m+2, etc.) observed by the indicated selected compound group. Fig. 6A Results before natural abundance correction are shown.

[0084] In contrast, Figure 6B is similar to Fig. 6A , showing an example of output data from the same experiment but after natural abundance correction has been performed. In this example, the isotopes corresponding to m+1 and m+2 have been removed from the isotopologue histogram after natural abundance correction.

[0085] Figure 77 is a schematic diagram of another example of a system or workflow 700 for data collection and analysis of samples according to the present disclosure, involving stable isotope labeling. In this embodiment, the method requires performing a differential analysis to determine the difference between a control sample from a control sample source 744 and a test sample from a test sample source 748. Sample sources 744 and 748 can be, for example, containers containing chemical mixtures, biological systems such as cell cultures, etc. The system or workflow 700 can generally be similar to that described above and in Figure 4 The system or workflow 400 shown in FIG. 4 need therefore include, in sequence, a sample preparation phase 704, a sample processing and analysis phase 708, and a data processing and analysis phase 712.

[0086] During the sample preparation phase 704, an unlabeled control sample 720 and an isotope-labeled control sample 724 are prepared. In addition, an unlabeled test sample 752 and an isotope-labeled test sample 756 are prepared. Samples 720, 724, 752, and 756 are chemically or biologically identical to each other, except that the desired isotope is incorporated into the compounds of the isotope-labeled control sample 724 and the isotope-labeled test sample 756 in the manner described above. In addition, the test samples 752 and 756 have been modified (e.g., perturbed, stimulated, excited, etc.) compared to the control samples 720 and 724. That is, at least one chemical or biological condition of at least one compound in the test samples 752 and 756 has been changed relative to the same chemical or biological conditions of the same compound of the control samples 720 and 724. The type of change will depend on the experiment. Examples include, but are not limited to, the addition of chemical agents or pathogens, electromagnetic irradiation, heat treatment, and the like.

[0087] During the sample processing and analysis phase 708, samples 720, 724, 752, and 756 are each introduced and run through an MS system, such as described above and in Figure 1A . The MS system 100 generates raw MS data 736 corresponding to each peak detected. The MS system 100 then transmits the raw MS data 736 to the data analyzer 190, or otherwise provides the MS data 736 to the data analyzer 190, as described above.

[0088] During the data processing and analysis phase 712, the data analyzer 190 receives raw MS data 736 from the MS system 100 or another source that may have stored the MS data 736, and processes and analyzes the raw MS data 736 according to the methods described herein. The methods may be substantially similar to those described above and in Figure 5. In the present embodiment, the data analyzer 190 extracts and analyzes features from the unlabeled control sample 720, the isotope-labeled control sample 724, the unlabeled test sample 752, and the isotope-labeled test sample 756. As a result, the data analyzer 190 generates output data 740. The output data 740 includes a set of output data 760 obtained by analyzing the raw MS data 736 collected from the control samples 720 and 724, and a set of output data 764 obtained by analyzing the raw MS data 736 collected from the test samples 752 and 756. In the present embodiment, the method further includes, after performing the target isotopologue extraction, performing a differential analysis 768 to determine the (statistically significant) difference between one or more isotope patterns of the unlabeled control sample 720 and the labeled control sample 724 and one or more isotope patterns of the unlabeled test sample 752 and the labeled test sample 756. Differential analysis 768 (eg, output data generated by differential analysis 768 ) may be used to determine, for example, the effects of changes in conditions on compounds of interest observed in samples 720 , 724 , 752 , and 756 .

[0089] As mentioned in the background technology section of the present disclosure, known non-target data analysis techniques may operate slowly and produce erroneous results, such as isotope gaps and incorrect isotope clusters, and may not be able to find random rather than continuous isotope incorporation. In contrast, the method disclosed herein provides a practical method for finding stable isotope label incorporation in a faster manner and with a lower error rate, and for accurately finding random and continuous isotope incorporation. The performance improvement achieved by the method disclosed herein is partly because the method is able to convert unlabeled data into empirical formulas, which are then used to mine labeled data. In addition, even if the generated empirical formula does not completely match the real compound, the method is effective because the empirical formula calculated using the mass value and isotope ratio of the compound spectrum will limit the empirical formula to a set of very similar empirical formulas.

[0090] For example, methods for analyzing samples such as those described above and shown in the accompanying drawings may be performed (implemented) in a system including, for example, a processor and a memory (such as may be embodied in, for example, a data analyzer or a computing device). Figure 1A The spectroscopy system shown in the figure may include a system for analyzing a sample, or be a part of it or communicate with it. As used herein, the term "perform" or "implement" may encompass actions such as control and / or signal or data transmission. For example, such as Figure 1A and 1BThe computing device or its processor shown may perform method steps by controlling another component involved in performing the method steps. Execution or control may involve performing calculations, or sending and / or receiving signals (e.g., control signals, instructions, measurement signals, parameter values, data, etc.).

[0091] As used herein, an "interface" or "user interface" is generally a system or device through which a user interacts with a computing device. An interface may include inputs (e.g., user input devices) for allowing a user to manipulate a computing device, and may include outputs (e.g., user output devices) for allowing the system to present information and / or data, indicating the effects of user manipulation, etc. Examples of interfaces on computing devices include graphical user interfaces (GUIs), which allow users to interact with programs in ways other than typing. Contrary to (or in addition to) text-based interfaces, typing command labels, or text navigation, a GUI typically can provide display objects and visual indicators to represent information and actions available to a user. For example, an interface may be a display window or a display object, and the interface may be selected by a user of a computing device for interaction. A display object may be displayed on a display screen of a computing device, and may be selected and interacted with by a user using an interface. In a non-limiting embodiment, the display of a computing device may be a touch screen, and the touch screen may display the display icon. A user may press on the touch screen to display the display icon to select an area where the display icon is displayed. In another embodiment, a user may select the display icon or display object using any other suitable interface of a computing device such as a keyboard. For example, a user may use a tracker ball or arrow keys to move a cursor to highlight and select the displayed object.

[0092] Exemplary embodiments

[0093] Exemplary embodiments provided according to the subject matter disclosed herein include, but are not limited to, the following:

[0094] 1. A method for analyzing a sample using stable isotope labeling, the method comprising: (a) receiving mass spectrometry (MS) data generated by an MS system that performs non-targeted data acquisition on a plurality of samples, wherein: the plurality of samples comprise: an unlabeled sample containing an unlabeled compound, and a labeled sample containing an isotope-labeled compound and being chemically or biologically equivalent to the unlabeled sample; the MS data comprises unlabeled compound data and labeled compound data; the unlabeled compound data comprises retention time data, mass-to-charge ratio (m / z) data, and abundance data corresponding to molecular features of the unlabeled sample detected by the MS system; and the labeled compound data comprises isotope-labeled compound data corresponding to the molecular features of the unlabeled sample detected by the MS system. (a) performing non-target feature extraction on the unlabeled compound data to generate a first extracted feature data set; (c) generating a plurality of empirical molecular formulas corresponding to the first extracted features; (d) performing targeted isotopologue extraction on the labeled compound data to generate a second extracted feature data set, wherein the targeted isotopologue extraction is based on the empirical molecular formula and retention time of each first extracted feature; and (e) identifying compounds incorporating stable labels by comparing the isotopologue pattern in the first extracted feature with the isotopologue pattern in the second extracted feature to determine whether there is a difference between the corresponding isotopologue patterns.

[0095] 2. The method according to embodiment 1, wherein the unlabeled compound and the isotope-labeled compound are non-biological compounds.

[0096] 3. A method according to embodiment 1, wherein the unlabeled compound and the isotope-labeled compound are biological compounds.

[0097] 4. The method according to any one of the preceding embodiments, wherein the MS data is selected from: chromatography / MS data; and capillary electrophoresis / MS data.

[0098] 5. A method according to any of the preceding embodiments, wherein the receiving is performed at a computing device comprising a processor and a memory.

[0099] 6. The method according to any one of the preceding embodiments, wherein the non-targeted feature extraction performed on the unlabeled compound data comprises performing recursive feature extraction.

[0100] 7. A method according to any one of the preceding embodiments, comprising removing low abundance features from a first extracted feature data set before generating a plurality of empirical formulas, wherein the low abundance features have an abundance below a minimum abundance threshold.

[0101] 8. The method according to any one of the preceding embodiments, comprising performing retention time alignment on the first extracted feature data set before generating a plurality of empirical formulas.

[0102] 9. A method according to any one of the preceding embodiments, wherein generating multiple empirical molecular formulas includes steps selected from the following: executing a molecular formula generation algorithm, wherein the molecular formula generation algorithm is configured to assign the empirical molecular formula to the corresponding first extracted feature based on isotope pattern matching; and executing a molecular formula generation algorithm, wherein the molecular formula generation algorithm is configured to assign the empirical molecular formula to the corresponding first extracted feature based on comparing the first extracted feature with known compounds contained in a database.

[0103] 10. The method according to embodiment 9 includes removing unassigned features from the first extracted feature data set before performing target isotopologue extraction, wherein the unassigned features are features that cannot be associated with a molecular formula after executing the molecular formula generation algorithm.

[0104] 11. A method according to any one of the preceding embodiments, wherein generating multiple empirical molecular formulas includes: executing a molecular formula generation algorithm, wherein the molecular formula generation algorithm is configured to assign scores to the first extracted features, with higher scores indicating closer isotope pattern matches; assigning the empirical molecular formulas to corresponding first extracted features having scores equal to or greater than a minimum score threshold; and removing low-scoring features from the first extracted feature data set, wherein the scores of the low-scoring features are lower than the minimum score threshold.

[0105] 12. The method according to any one of the preceding embodiments, comprising performing natural isotope abundance correction on the unlabeled compound data and the labeled compound data after performing target isotopologue extraction.

[0106] 13. A method according to any of the preceding embodiments, wherein the labeled sample is prepared by applying an isotopic tracer to the labeled sample, and the method further comprises performing an isotopic tracer purity correction on the labeled compound data after performing target isotopologue extraction.

[0107] 14. A method according to any one of the preceding embodiments, comprising, after performing target isotopologue extraction, removing first extracted features of unidentified isotopologues from a first extracted feature data set, and removing second extracted features of unidentified isotopologues from a second extracted feature data set.

[0108] 15. A method according to any one of the preceding embodiments, wherein: the unlabeled compound and the isotope-labeled compound are, respectively, a first unlabeled compound and a first isotope-labeled compound extracted from a sample source at a first time point; the MS data is first MS data collected from the first unlabeled compound and the first isotope-labeled compound; and the method further includes repeating steps (a)-(e) at a second time point after the first time point using second MS data collected from a second unlabeled compound and a second isotope-labeled compound extracted from the sample source.

[0109] 16. The method of embodiment 15, wherein the sample source is a biological system, the first unlabeled compound and the first isotope-labeled compound are first metabolites, and the second unlabeled compound and the second isotope-labeled compound are second metabolites.

[0110] 17. A method according to an embodiment, wherein: the unlabeled sample is an unlabeled control sample, the labeled sample is a labeled control sample, the first extracted feature is the first extracted feature of the unlabeled control sample, and the second extracted feature is the second extracted feature of the labeled control sample; the multiple samples further include an unlabeled test sample and a labeled test sample, the unlabeled test sample and the labeled test sample are chemically or biologically equivalent to the unlabeled control sample and the labeled control sample, and have chemical or biological conditions that are changed relative to the chemical or biological conditions of the unlabeled control sample and the labeled control sample; and the method further includes performing steps (a)-(e) on the unlabeled test sample and the labeled test sample to generate a data set of extracted features of the unlabeled test sample and the extracted features of the labeled test sample.

[0111] 18. The method according to embodiment 17 includes, after performing target isotopologue extraction, performing differential analysis to determine the difference between the isotopic patterns of the unlabeled control sample and the labeled control sample and the isotopic patterns of the unlabeled test sample and the labeled test sample.

[0112] 19. The method of embodiment 17 or 18, wherein the unlabeled control sample, the labeled control sample, the unlabeled test sample, and the labeled test sample comprise metabolites.

[0113] 20. The method according to any one of the preceding embodiments, comprising acquiring the MS data by processing the sample in an MS system.

[0114] 21. A system for analyzing a sample, the system comprising: a controller configured to receive MS data and control or execute all or part of the steps of the method according to any one of the preceding embodiments.

[0115] 22. A non-transitory computer readable medium comprising instructions stored thereon, which when executed on a processor control or perform the method according to any one of the preceding embodiments.

[0116] 23. A system comprising a computer-readable storage medium according to embodiment 22.

[0117] It should be understood that one or more of the processes, sub-processes, and process steps described herein may be performed by hardware, firmware, software, or a combination of two or more of the foregoing on one or more electronic or numerically controlled devices. The software may reside on a suitable electronic processing component or system (such as, for example, Figure 1A and Figure 1B The software memory may include an ordered list of executable instructions for implementing logical functions (i.e., "logic" that may be implemented in digital form, such as digital circuits or source code; or "logic" that may be implemented in analog form, such as analog sources such as analog electricity, sound or video signals). The instructions may be executed within a processing module, which may include, for example, one or more microprocessors, general-purpose processors, processor combinations, digital signal processors (DSPs), or application-specific integrated circuits (ASICs). In addition, the schematic diagrams describe a logical partitioning of functions with physical (hardware and / or software) implementations that are not limited by the architecture or physical layout of the functions. The examples of the systems described herein may be implemented in various configurations and operated as hardware / software components in a single hardware / software unit or as hardware / software components in separate hardware / software units.

[0118] These executable instructions may be implemented as a computer program product having instructions stored therein, which when executed by a processing module (e.g., Figure 1A and Figure 1BWhen the computer program product is executed by the computing device 118 or data analyzer 190 in the computer system, these instructions guide the electronic system to execute these instructions. The computer program product can be selectively included in any non-transient computer-readable storage medium for use by or in combination with an instruction execution system, device or equipment, such as a system based on an electronic computer, a system containing a processor, or other systems that can selectively obtain instructions from the instruction execution system, device or equipment and execute these instructions. In the context of the present disclosure, a computer-readable storage medium is any non-transient device that can store programs for use by or in combination with an instruction execution system, device or equipment. A non-transient computer-readable storage medium can selectively be, for example, an electronic, magnetic, optical, electromagnetic, infrared or semiconductor system, device or equipment. A non-exhaustive list of more specific examples of non-transitory computer-readable media includes: an electrical connection with one or more wires (electronic); a portable computer disk (magnetic); a random access memory (electronic); a read-only memory (electronic); an erasable programmable read-only memory, such as flash memory (electronic); optical disk storage, such as CD-ROM, CD-R, CD-RW (optical); and digital versatile disk storage, i.e., DVD (optical). Note that the non-transitory computer-readable storage medium may even be another suitable medium of a paper or printed program, as the program may be captured electronically, such as by optical scanning of a paper or other medium, and then compiled, interpreted, or otherwise processed in a suitable manner if desired, and then stored in a computer memory or machine storage.

[0119] It should also be understood that the term "communication with signals" used herein means that two or more systems, devices, components, modules or submodules can communicate with each other via signals running on some types of signal paths. Signals can be communication, electric power, data or energy signals, which can transmit information, electric power or energy from a first system, device, component, module or submodule to a second system, device, component, module or submodule along the signal path between the first and second systems, devices, components, modules or submodules. The signal path can include physical, electrical, magnetic, electromagnetic, electrochemical, optical, wired or wireless connections. The signal path can also include other systems, devices, components, modules or submodules between the first and second systems, devices, components, modules or submodules.

[0120] More generally, terms such as "communicate" and "communicate / communicate with" (e.g., a first component "communicates / communicates with" or is in "communicating / communicating with" a second component) are used herein to indicate a structural, functional, mechanical, electrical, signal, optical, magnetic, electromagnetic, ionic, or fluid relationship between two or more components or elements. Thus, the fact that one component is referred to as being in communication / communicate with a second component is not intended to exclude the possibility that other components exist between the first component and the second component and / or that the other components are operably associated or engaged with the first component and the second component.

[0121] It will be appreciated that various aspects or details of the invention may be changed without departing from the scope of the invention. Furthermore, the foregoing description is for purposes of illustration only and not of limitation - the invention being defined by the claims.

Claims

1. A method for analyzing a sample using stable isotope labeling and tracing, the method comprising: include: (a) receiving, at a computing device comprising a processor and a memory, mass spectrometry (MS) data generated by an MS system performing non-targeted data acquisition on a plurality of samples, wherein: The plurality of samples include an unlabeled sample containing an unlabeled compound, and a labeled sample containing an isotope-labeled compound and being chemically or biologically equivalent to the unlabeled sample; The MS data includes unlabeled compound data and labeled compound data; The unlabeled compound data includes retention time data, mass-to-charge ratio ( m / z ) data and abundance data; and The labeled compound data includes retention time data corresponding to molecular features of the labeled sample detected by the MS system, m / z data and abundance data; (b) performing non-target feature extraction on the unlabeled compound data to generate a first extracted feature data set; (c) generating a plurality of empirical molecular formulas respectively corresponding to the first extracted features; (d) performing targeted isotopologue extraction on the labeled compound data to generate a second extracted feature data set, wherein the targeted isotopologue extraction is based on an empirical molecular formula and retention time of each first extracted feature; and (e) identifying the compound incorporating the stable label by comparing the isotopologue pattern in the first extracted feature to the isotopologue pattern in the second extracted feature to determine whether there is a difference between the corresponding isotopologue patterns; Wherein generating a plurality of empirical molecular formulas comprises at least one of the following steps: executing a molecular formula generation algorithm configured to assign the empirical molecular formula to a corresponding first extracted feature based on isotope pattern matching; executing a molecular formula generation algorithm, the molecular formula generation algorithm being configured to assign the empirical molecular formula to corresponding first extracted features based on isotope pattern matching, and removing unassigned features from the first extracted feature dataset before performing target isotopologue extraction, wherein the unassigned features are features that cannot be associated with a molecular formula after executing the molecular formula generation algorithm; executing a molecular formula generation algorithm, the molecular formula generation algorithm being configured to assign the empirical molecular formula to the corresponding first extracted feature based on comparing the first extracted feature with known compounds contained in a database; Executing a molecular formula generation algorithm, the molecular formula generation algorithm is configured to assign the empirical molecular formula to the corresponding first extracted feature based on comparing the first extracted feature with known compounds contained in a database, and before performing target isotopologue extraction, remove unassigned features from the first extracted feature dataset, wherein the unassigned features are features that cannot be associated with a molecular formula after executing the molecular formula generation algorithm.

2. The method according to claim 1, wherein include: Before generating the plurality of empirical formulas, at least one of the following is performed: removing low abundance features from the first extracted feature dataset, wherein the low abundance features have an abundance below a minimum abundance threshold; Retention time alignment is performed on the first extracted feature data set.

3. The method according to claim 1 or 2, wherein generating a plurality of empirical molecular formulas further comprises: The following steps are involved: A molecular formula generation algorithm is executed, the molecular formula generation algorithm being configured to assign scores to the first extracted features, with higher scores indicating closer isotope pattern matches, assign the empirical molecular formula to corresponding first extracted features having scores equal to or greater than a minimum score threshold, and remove low scoring features from the first extracted feature dataset, wherein the scores of the low scoring features are below the minimum score threshold.

4. The method according to claim 1 or 2, comprising, after performing the target isotopologue extraction, performing at least one of the following: performing natural isotope abundance correction on the unlabeled compound data and the labeled compound data; First extracted features for which isotopologues are not identified are removed from the first extracted features dataset, and second extracted features for which isotopologues are not identified are removed from the second extracted features dataset.

5. The method of claim 1 or 2, wherein the labeled sample is prepared by applying an isotopic tracer to the labeled sample, and the method further comprises performing an isotopic tracer purity correction on the labeled compound data after performing target isotopologue extraction.

6. The method according to claim 1 or 2, in: The unlabeled compound and the isotope-labeled compound are respectively a first unlabeled compound and a first isotope-labeled compound extracted from a sample source at a first time point, The MS data is first MS data collected from the first unlabeled compound and the first isotope-labeled compound; The method further comprises repeating steps (a)-(e) at a second time point after the first time point using second MS data acquired from a second unlabeled compound and a second isotopically labeled compound extracted from the sample source; and Wherein the sample source is a biological system, the first unlabeled compound and the first isotope-labeled compound are first metabolites, and the second unlabeled compound and the second isotope-labeled compound are second metabolites.

7. The method according to claim 1 or 2, in: The unlabeled sample is an unlabeled control sample, the labeled sample is a labeled control sample, the first extracted feature is a first extracted feature of the unlabeled control sample, and the second extracted feature is a second extracted feature of the labeled control sample; The plurality of samples further include unlabeled test samples and labeled test samples that are chemically or biologically equivalent to the unlabeled control sample and the labeled control sample and have chemical or biological conditions that are altered relative to the chemical or biological conditions of the unlabeled control sample and the labeled control sample; and The method further includes performing steps (a)-(e) on the unlabeled test sample and the labeled test sample to generate a dataset of extracted features of the unlabeled test sample and extracted features of the labeled test sample.

8. The method of claim 7, comprising, after performing targeted isotopologue extraction, performing a differential analysis to determine the difference between the isotopic patterns of the unlabeled control sample and the labeled control sample and the isotopic patterns of the unlabeled test sample and the labeled test sample.

9. The method of claim 7, wherein the unlabeled control sample, the labeled control sample, the unlabeled test sample, and the labeled test sample comprise metabolites.

10. The method of claim 1 or 2, wherein the mass spectrometry (MS) data is chromatography / MS data or capillary electrophoresis / MS data.

11. The method according to claim 1 or 2, wherein the unlabeled compound and the isotope-labeled compound are non-biological compounds or biological compounds.

12. The method of claim 1 or 2, wherein performing non-targeted feature extraction on the unlabeled compound data comprises performing recursive feature extraction.

13. A non-transitory computer readable medium comprising instructions stored thereon which, when executed on a processor, control or perform the method according to any one of the preceding claims.